BFM
TWST icon

Boothbay Fund Management’s Twist Bioscience TWST Stock Holding History

Boothbay Fund Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-138
Closed -$1.71M – 2125
2021
Q1 		$1.71M Buy
+138
New +$21K 0.06% 376

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Boothbay Fund Management's TWST Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Twist Bioscience (TWST) in Q2 2026: 14,955 shares worth $1.54M. The stake represents 0.02% of the portfolio and ranks #865 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in TWST as recently as Q2 2024.

Boothbay Fund Management first reported a position in TWST in Q2 2024 and has held it in 2 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Boothbay Fund Management held 14,955 shares of Twist Bioscience worth $1.54M as of Q2 2026.
  • Twist Bioscience was a new Boothbay Fund Management position in Q2 2026.
  • Twist Bioscience made up 0.02% of Boothbay Fund Management's portfolio in Q2 2026, its #865 holding.
  • Boothbay Fund Management first reported a position in Twist Bioscience in Q2 2024 and has held it in 2 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.